These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23000075)

  • 1. In vivo evaluation of antimyotonic efficacy of β-adrenergic drugs in a rat model of myotonia.
    Desaphy JF; Costanza T; Carbonara R; Conte Camerino D
    Neuropharmacology; 2013 Feb; 65():21-7. PubMed ID: 23000075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs.
    Desaphy JF; Carbonara R; Costanza T; Conte Camerino D
    Exp Neurol; 2014 May; 255(100):96-102. PubMed ID: 24613829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo.
    Desaphy JF; Farinato A; Altamura C; De Bellis M; Imbrici P; Tarantino N; Caccia C; Melloni E; Padoani G; Vailati S; Keywood C; Carratù MR; De Luca A; Conte D; Pierno S
    Exp Neurol; 2020 Jun; 328():113287. PubMed ID: 32205118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity.
    De Bellis M; Carbonara R; Roussel J; Farinato A; Massari A; Pierno S; Muraglia M; Corbo F; Franchini C; Carratù MR; De Luca A; Conte Camerino D; Desaphy JF
    Neuropharmacology; 2017 Feb; 113(Pt A):206-216. PubMed ID: 27743929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the antimyotonic activity of mexiletine and some new analogs on sodium currents of single muscle fibers and on the abnormal excitability of the myotonic ADR mouse.
    De Luca A; Pierno S; Natuzzi F; Franchini C; Duranti A; Lentini G; Tortorella V; Jockusch H; Camerino DC
    J Pharmacol Exp Ther; 1997 Jul; 282(1):93-100. PubMed ID: 9223544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse.
    De Luca A; Pierno S; Liantonio A; Desaphy JF; Natuzzi F; Didonna MP; Ferrannini E; Jockusch H; Franchini C; Lentini G; Corbo F; Tortorella V; Camerino DC
    Neuromuscul Disord; 2004 Jul; 14(7):405-16. PubMed ID: 15210163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of myotonia with antiarrhythmic drugs.
    Kwieciński H; Ryniewicz B; Ostrzycki A
    Acta Neurol Scand; 1992 Oct; 86(4):371-5. PubMed ID: 1455983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockers of Skeletal Muscle Na
    De Bellis M; Boccanegra B; Cerchiara AG; Imbrici P; De Luca A
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homologation of mexiletine alkyl chain and stereoselective blockade of skeletal muscle sodium channels.
    Duranti A; Franchini C; Lentini G; Loiodice F; Tortorella V; De Luca A; Pierno S; Conte Camerino D
    Eur J Med Chem; 2000 Jan; 35(1):147-56. PubMed ID: 10733611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different ability of clenbuterol and salbutamol to block sodium channels predicts their therapeutic use in muscle excitability disorders.
    Desaphy JF; Pierno S; De Luca A; Didonna P; Camerino DC
    Mol Pharmacol; 2003 Mar; 63(3):659-70. PubMed ID: 12606775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of myotonic hNav1.4 sodium channel variants situated near the fast inactivation gate.
    Farinato A; Altamura C; Imbrici P; Maggi L; Bernasconi P; Mantegazza R; Pasquali L; Siciliano G; Lo Monaco M; Vial C; Sternberg D; Carratù MR; Conte D; Desaphy JF
    Pharmacol Res; 2019 Mar; 141():224-235. PubMed ID: 30611854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block.
    Desaphy JF; De Luca A; Didonna MP; George AL; Camerino Conte D
    J Physiol; 2004 Jan; 554(Pt 2):321-34. PubMed ID: 14608015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study.
    Andersen G; Hedermann G; Witting N; Duno M; Andersen H; Vissing J
    Brain; 2017 Sep; 140(9):2295-2305. PubMed ID: 29050397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased rigidity of the chiral centre of tocainide favours stereoselectivity and use-dependent block of skeletal muscle Na(+) channels enhancing the antimyotonic activity in vivo.
    Talon S; De Luca A; De Bellis M; Desaphy JF; Lentini G; Scilimati A; Corbo F; Franchini C; Tortorella P; Jockusch H; Conte Camerino D
    Br J Pharmacol; 2001 Dec; 134(7):1523-31. PubMed ID: 11724759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myotonia with muscular weakness corrected by exercise. The therapeutic effect of mexiletine].
    Pouget J; Serratrice G
    Rev Neurol (Paris); 1983; 139(11):665-72. PubMed ID: 6677978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing of sodium channel antagonists as potential new anti-myotonic drugs.
    Matthews E; Hanna MG
    Exp Neurol; 2014 Nov; 261():812-5. PubMed ID: 25218042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of frog skeletal muscle sodium channels by newly synthesized chiral derivatives of mexiletine and tocainide.
    De Luca A; Natuzzi F; Falcone G; Duranti A; Lentini G; Franchini C; Tortorella V; Camerino DC
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):777-87. PubMed ID: 9453464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Insights into the Local Anesthetic Receptor within Voltage-Gated Sodium Channels Using Hydroxylated Analogs of Mexiletine.
    Desaphy JF; Dipalma A; Costanza T; Carbonara R; Dinardo MM; Catalano A; Carocci A; Lentini G; Franchini C; Camerino DC
    Front Pharmacol; 2012; 3():17. PubMed ID: 22403541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Benzothiazolamines on Voltage-Gated Sodium Channels.
    Farinato A; Altamura C; Desaphy JF
    Handb Exp Pharmacol; 2018; 246():233-250. PubMed ID: 28939972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimyotonic effects of tocainide enantiomers on skeletal muscle fibers of congenitally myotonic goats.
    Camerino DC; Pierno S; De Luca A; Bryant SH
    Neuromuscul Disord; 2000 Mar; 10(3):160-4. PubMed ID: 10734261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.